Dublin, May 14, 2021 (GLOBE NEWSWIRE) -- The "Global Chronic Obstructive Pulmonary Disease Epidemiology and Patient Flow - 2021" report has been added to ResearchAndMarkets.com's offering.

Global Chronic Obstructive Pulmonary Disease Epidemiology and Patient Flow Analysis - 2021, provides Chronic Obstructive Pulmonary Disease epidemiology, demographics, and patient flow. The data is presented by Pharma G7 countries including the US, France, Spain, Italy, UK, Japan.

The research provides population data to characterize Chronic Obstructive Pulmonary Disease patients, history of the disease at the population level (Chronic Obstructive Pulmonary Disease prevalence, Chronic Obstructive Pulmonary Disease incidence) and at the clinical level (from diagnosis to treated patients). It also helps to identify patient sub-groups (age, gender, sub-groups) to understand targeted population for research and development, commercialization.

Research scope:

The data from this research will help executives:

Key Topics Covered:

1. Research Methodology

2. Chronic Obstructive Pulmonary Disease Patients Definition

3. US Chronic Obstructive Pulmonary Disease Epidemiology and Patient Flow

4. Germany Chronic Obstructive Pulmonary Disease Epidemiology and Patient Flow

5. France Chronic Obstructive Pulmonary Disease Epidemiology and Patient Flow

6. Italy Chronic Obstructive Pulmonary Disease Epidemiology and Patient Flow

7. Spain Chronic Obstructive Pulmonary Disease Epidemiology and Patient Flow

8. UK Chronic Obstructive Pulmonary Disease Epidemiology and Patient Flow

9. Europe Chronic Obstructive Pulmonary Disease Epidemiology and Patient Flow

10. Japan Chronic Obstructive Pulmonary Disease Epidemiology and Patient Flow

11. Global Chronic Obstructive Pulmonary Disease Epidemiology and Patient Flow

For more information about this report visit https://www.researchandmarkets.com/r/6byrpu